I Richard Steinhart
Affiliations
- Chief Financial Officer at Bioxcel Therapeutics Inc. (BTAI), 2025-06-16
- at Atossa Therapeutics Inc. (ATOS), 2025-05-16
- Director at Actinium Pharmaceuticals Inc. (ATNM), 2025-04-02
- Chief Financial Officer at Mela Sciences Inc. (MELA), 2013-08-08
- Director at Manhattan Pharmaceuticals Inc (MHAN), 2010-03-10
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BTAI | $5.20 | 500 | $2,599.95 | 1,500 | 2018-12-03 | Filing |
| BTAI | $5.00 | 500 | $2,500.00 | 1,000 | 2018-11-30 | Filing |
| BTAI | $5.00 | 500 | $2,500.00 | 500 | 2018-11-29 | Filing |
| ATNM | $2.01 | 2,500 | $5,025.00 | 2,500 | 2016-04-14 | Filing |
| MELA | $0.81 | 3,000 | $2,427.00 | 4,000 | 2013-06-25 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BTAI | $0.36 | 372 | $133.18 | 20,932 | 2024-12-16 | Filing |
| BTAI | $0.36 | 205 | $73.80 | 21,157 | 2024-12-16 | Filing |
| BTAI | $0.55 | 7,175 | $3,946.25 | 20,279 | 2024-10-03 | Filing |
| BTAI | $0.69 | 356 | $245.60 | 6,204 | 2024-09-16 | Filing |
| BTAI | $1.26 | 372 | $469.54 | 5,476 | 2024-06-17 | Filing |